An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

Ischemic stroke remains one of the leading causes of death and long-term disability worldwide, with narrowing of the carotid artery due to atherosclerosis contributing to up to 30% of all cases.

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Ischemic stroke remains one of the leading causes of death and long-term disability worldwide, with narrowing of the carotid ...

SEAL Hemostatic Would Spray is the first and only FDA-cleared aerosolized chitosan for rapid management of serious arterial bleeding. Marking a significant advancement in emergency medical response ...

Elk hunter Henry Rauschenbach’s near-death story is a gut-wrenching, inspiring account of wilderness survival.

(4) Patients with non-atherosclerotic causes of occlusion, including arterial dissection, cardiogenic embolism, vasculitis, history of radiotherapy, or congenital vascular malformations. (5) History ...

Digital subtraction angiography (DSA) identified a rupture of a left fourth lumbar segmental artery branch. Emergency coil embolization was performed to control the bleeding. Four weeks later, due to ...

Recent randomized control trials have demonstrated the efficacy and safety of middle meningeal artery embolization (MMAE) as an adjunct to conventional management for patients with nonacute subdural ...

The HOST-BR trial demonstrated that for patients at either high or low risk of bleeding, 3 months is the optimal duration of treatment to reduce adverse events without increasing bleeding risk ...